<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mem Inst Oswaldo Cruz</journal-id><journal-id journal-id-type="iso-abbrev">Mem. Inst. Oswaldo Cruz</journal-id><journal-title-group><journal-title>Mem&#x000f3;rias do Instituto Oswaldo Cruz</journal-title></journal-title-group><issn pub-type="ppub">0074-0276</issn><issn pub-type="epub">1678-8060</issn><publisher><publisher-name>Instituto Oswaldo Cruz, Minist&#x000e9;rio da Sa&#x000fa;de</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4660618</article-id><article-id pub-id-type="pmid">26560979</article-id><article-id pub-id-type="doi">10.1590/0074-02760150175</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Identification of the nicotinamide mononucleotide adenylyltransferase of<italic>Trypanosoma cruzi</italic>
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ni&#x000f1;o</surname><given-names>Carlos H</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Forero-Baena</surname><given-names>Nicol&#x000e1;s</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Contreras</surname><given-names>Luis E</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;nchez-Lancheros</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Figarella</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ram&#x000ed;rez</surname><given-names>Mar&#x000ed;a H</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="c01">
<sup>+</sup>
</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Universidad Nacional de Colombia, Facultad de Ciencias, Laboratorio de
Investigaciones B&#x000e1;sicas en Bioqu&#x000ed;mica, Bogot&#x000e1;, Colombia</aff><aff id="aff2"><label>2</label>Fundaci&#x000f3;n Instituto de Estudios Avanzados, Caracas, Venezuela</aff><author-notes><corresp id="c01"><label>+</label> Corresponding author: <email>mhramirezh@unal.edu.co</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>11</month><year>2015</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>11</month><year>2015</year></pub-date><volume>110</volume><issue>7</issue><fpage>890</fpage><lpage>897</lpage><history><date date-type="received"><day>8</day><month>5</month><year>2015</year></date><date date-type="accepted"><day>5</day><month>8</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p></license></permissions><abstract><p>The intracellular parasite <italic>Trypanosoma</italic> cruzi is the aetiological
agent of Chagas disease, a public health concern with an increasing incidence rate.
This increase is due, among other reasons, to the parasite's drug resistance
mechanisms, which require nicotinamide adenine dinucleotide (NAD<sup>+</sup>).
Furthermore, this molecule is involved in metabolic and intracellular signalling
processes necessary for the survival of <italic>T. cruzi</italic> throughout its life
cycle. NAD<sup>+</sup> biosynthesis is performed by <italic>de novo</italic> and
salvage pathways, which converge on the step that is catalysed by the enzyme
nicotinamide mononucleotide adenylyltransferase (NMNAT) (enzyme commission
<italic>number</italic>: 2.7.7.1). The identification of the NMNAT of <italic>T.
cruzi</italic> is important for the development of future therapeutic strategies
to treat Chagas disease. In this study, a hypothetical open reading frame (ORF) for
NMNAT was identified in the genome of <italic>T. cruzi</italic>. The corresponding
putative protein was analysed by simulating structural models. The ORF was amplified
from genomic DNA by polymerase chain reaction and was further used for the
construction of a corresponding recombinant expression vector. The expressed
recombinant protein was partially purified and its activity was evaluated using
enzymatic assays. These results comprise the first identification of an NMNAT in
<italic>T. cruzi</italic> using bioinformatics and experimental tools and hence
represent the first step to understanding NAD<sup>+</sup> metabolism in these
parasites.</p></abstract><kwd-group><kwd>nicotinamide adenine dinucleotide</kwd><kwd>nicotinic acid mononucleotide</kwd><kwd>nicotinamide mononucleotide</kwd><kwd>nicotinamide mononucleotide adenylyltransferase</kwd><kwd><italic>Trypanosoma cruzi</italic></kwd><kwd>Chagas disease</kwd></kwd-group><counts><fig-count count="7"/><table-count count="1"/><equation-count count="0"/><ref-count count="35"/><page-count count="8"/></counts></article-meta></front><body><p>Nicotinamide adenine dinucleotide (NAD<sup>+</sup>) and its phosphorylated form
(NADP<sup>+</sup>) are vital coenzymes for cellular physiology in all organisms. These
dinucleotides perform important functions in cellular basal metabolism and cellular
antioxidant mechanisms (Kirsch &#x00026; De Groot 2001, <xref rid="B15" ref-type="bibr">Ghosh
et al. 2010)</xref>. NAD<sup>+</sup> has an equally important function as a substrate
and is involved in multiple cellular signalling processes (<xref rid="B3" ref-type="bibr">Berger et al. 2004)</xref>. Because of this role, NAD<sup>+</sup> is continuously
consumed and thus, its synthesis is essential to maintain cellular homeostasis. NAD<sup>+
</sup>synthesis occurs <italic>via</italic> two pathways: <italic>de novo</italic>
synthesis and salvage pathways. In both cases, nicotinic acid mononucleotide (NAMN) and
nicotinamide mononucleotide (NMN) are synthesised, with the subsequent synthesis of
NAD<sup>+</sup> from these precursors. In the final stage, both synthetic pathways must
converge on the reaction catalysed by NMN adenylyltransferase (NMNAT) [enzyme commission
number (EC): 2.7.7.1], which transfers the adenylate from adenosine triphosphate (ATP) to
any of the mononucleotides (NMN or NAMN), producing NAD<sup>+</sup> or nicotinic acid
adenine dinucleotide (NAAD) along with pyrophosphate (<xref rid="B16" ref-type="bibr">Jayaram et al. 2011)</xref>. NMNAT has been identified in archaebacteria, eubacteria
and eukaryotes. Nonetheless, despite their ubiquity, large differences exist between these
enzymes in terms of substrate specificity, oligomerisation capabilities and sensitivity to
divalent cationic cofactors (<xref rid="B20" ref-type="bibr">Lau et al. 2009)</xref>.</p><p>
<italic>Trypanosoma cruzi </italic>is a trypanosomatid that causes Chagas disease, an
important public health concern in Latin American countries given its high prevalence and
its high morbidity and mortality rates (Rassi Jr et al. 2012). The increase in diseases
caused by trypanosomatids is largely due to the development of resistance to commonly used
drugs against these parasites (<xref rid="B5" ref-type="bibr">Borges et al. 2005</xref>).
Redox systems are fundamental for the survival and drug resistance of intracellular
parasites (<xref rid="B19" ref-type="bibr">Krauth-Siegel et al. 2003</xref>, <xref rid="B23" ref-type="bibr">M&#x000fc;ller et al. 2003</xref>). All known resistance mechanisms
require NAD<sup>+</sup> for their operation (<xref rid="B23" ref-type="bibr">M&#x000fc;ller et al.
2003</xref>, <xref rid="B32" ref-type="bibr">Turrens 2004</xref>). Moreover, NAD(P)
biosynthetic pathways can be considered a generous source of enzymatic targets for drug
development (<xref rid="B21" ref-type="bibr">Magni et al. 2009</xref>). The study of
NAD<sup>+</sup> metabolism in <italic>T. cruzi</italic> would allow for the design of
strategies for the treatment of Chagas disease given the importance of this nucleotide.
Consequently, the identification of NMNAT enzymes in this parasite would represent an
increase in knowledge of NAD<sup>+</sup>synthesis and aid in the search for new drug
targets.</p><p>This paper presents, for the first time, the <italic>in silico </italic>identification of
an NMNAT of <italic>T. cruzi</italic> (TcNMNAT) using cloning and the heterologous
expression of a candidate gene to confirm its identity using direct enzymatic assays.</p><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><p>
<italic>Bioinformatic identification of TcNMNAT</italic> - Initially, to obtain
candidate sequences, a multiple alignment was performed of 16 amino acid (aa) sequences
corresponding to several NMNATs of various organisms with varying degrees of
phylogenetic divergence. Such sequences were indexed and manually annotated in the
UniProtKB protein database (<xref rid="B33" ref-type="bibr">UniProt Consortium
2014</xref>). To perform the alignment, the Multiple Sequence Comparison by
Log-Expectation algorithm (<xref rid="B9" ref-type="bibr">Edgar 2004</xref>) embedded as
a plugin in the software CLC Sequence Viewer v.6.9 (CLC bio<italic>,</italic>Denmark)
was used. The resulting consensus sequence was used to search the genomes of the
available <italic>T. cruzi </italic>strains using the BLASTP algorithm in the
trypanosomatid TriTrypDB database (<xref rid="B1" ref-type="bibr">Aslett et al.
2010</xref>).</p><p>
<italic>Bioinformatic analysis of the TcNMNAT putative protein structure</italic> - The
primary, secondary and tertiary structures of the TcNMNAT protein encoded in
the<italic>T. cruzi </italic>CL Brener Esmeraldo-like genome were analysed. The
web-based tool ProtParam from the ExPASy server (<xref rid="B14" ref-type="bibr">Gasteiger et al. 2003</xref>) was used for the analysis of the primary structure and
provided predictions of different physicochemical aspects of the protein, such as length
and molecular mass. The secondary structure patterns were predicted using three
different algorithms that were located on the web-based server NPS@ for network protein
sequence analysis (<xref rid="B7" ref-type="bibr">Combet et al. 2000</xref>): the GORIV
algorithm (<xref rid="B13" ref-type="bibr">Garnier et al. 1996</xref>), the
third-generation algorithm PHD (<xref rid="B28" ref-type="bibr">Rost &#x00026; Sander
1993</xref>) and the PREDATOR algorithm (<xref rid="B12" ref-type="bibr">Frishman
&#x00026; Argos 1996)</xref>. For the prediction of the tertiary structure and for the
assignment of a hypothetical function, a tridimensional model of the putative sequence
was performed using the I-TASSER server (<xref rid="B34" ref-type="bibr">Zhang
2008</xref>, <xref rid="B29" ref-type="bibr">Roy et al. 2010, 2012)</xref>, <xref rid="B30" ref-type="bibr">2012</xref>). The parameters that were chosen from this
server were the best tridimensional model that was generated, the prediction of the
Enzyme Commission Number EC number and the gene ontology (GO) terms. The tridimensional
model that was generated was used for a structural alignment with the HsNMNAT-1 model
(<italic>PDB ID:</italic> 1KQO) (<xref rid="B35" ref-type="bibr">Zhou et al.
2002)</xref>, which was generated from the X-Ray Diffraction (XRD) database and
registered on the PDB database (<xref rid="B4" ref-type="bibr">Bernstein et al.
1978)</xref>. This process was performed using UCSF Chimera v.1.8 software (<xref rid="B25" ref-type="bibr">Pettersen et al. 2004)</xref>.</p><p>
<italic>T. cruzi culture and DNA extraction</italic> - <italic>T.
cruzi</italic>epimastigotes were cultured at 27&#x000ba;C in Schneider medium (Sigma S9895) that
was supplemented with 10% (v/v) foetal bovine serum (Gibco) (<xref rid="B2" ref-type="bibr">Baker &#x00026; Price 1973</xref>, <xref rid="B22" ref-type="bibr">Miralles et
al. 2002)</xref>. DNA was extracted from 1 x 10<sup>7</sup> epimastigotes using the
phenol chloroform method (<xref rid="B24" ref-type="bibr">Pereira et al.
2000)</xref>.</p><p>
<italic>Amplification of the coding fragment of TcNMNAT</italic> - The amplification was
performed by polymerase chain reaction (PCR) using the primers 5'-CACCATGAGCGATGACACA-3&#x000b4;
and 5'-TCAACAATTTTGAGTATTGTTTG-3' (<xref rid="B8" ref-type="bibr">Dieffenbach et al.
1993</xref>). Amplification was performed using two systems. The fragment's initial
amplification was achieved with a Platinum<sup>&#x000ae;</sup> PCR SuperMix High Fidelity
(Invitrogen) system using 200 ng of genomic DNA as a template. An initial denaturation
step of 5 min at 94&#x000ba;C was used, followed by 30 cycles of denaturation at 94&#x000ba;C for 30 s,
annealing at 50&#x000ba;C for 30 s and extension at 72&#x000ba;C for 1 min. The final extension step was
10 min at 72&#x000ba;C. A second amplification was subsequently performed using 1 &#x003bc;L of the
previous PCR product as template; in this case, a Pfu DNA Polymerase system (Fermentas,
USA) was used. The initial denaturation was 5 min at 95&#x000ba;C, followed by 30 cycles of
denaturation at 95&#x000ba;C for 30 s, annealing at 50&#x000ba;C for 30 s and extension at 72&#x000ba;C for 2
min. The final extension step was 10 min at 72&#x000ba;C.</p><p>
<italic>Cloning and expression of TcNMNAT</italic> - Using the amplified fragment and
the pET100 D-TOPO Vector (Invitrogen), the construct pET100 D-TOPO-TcNMNAT was designed.
The insertion of the PCR fragment was verified using digestion with the restriction
enzyme EcoRV (Fermentas). Using this construct, <italic>Escherichia coli</italic> BL21
(DE3) cells were transformed by thermal shock. The transformed clones were inoculated
into liquid Luria broth (LB) that was supplemented with 100 &#x003bc;g/mL ampicillin and
incubated overnight at 37&#x000ba;C. The cultures were diluted (1:50) in the same medium. When
the cultures reached an optical density at 600<sub>nm</sub> of 0.6, the recombinant
protein was induced overnight at 37&#x000ba;C using isopropyl &#x003b2;-D-1-thiogalactopyranoside (IPTG)
at a final concentration of 1 mM. The recombinant protein was expressed with a histidine
tag (6xHis) on its N-terminus to allow for its detection and further purification. The
expression of the recombinant protein was confirmed using sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting (WB) (<xref rid="B11" ref-type="bibr">Fra et al. 1995</xref>, <xref rid="B26" ref-type="bibr">Ramprasad et al. 1996</xref>)<italic>.</italic>
</p><p>
<italic>Purification of 6xHis-TcNMNAT</italic> - The induced BL21 (DE3) cell cultures
were centrifuged at 4,000 <italic>g </italic>for 15 min at 4&#x000ba;C and resuspended in lysis
buffer (300 mM NaCl; 50 mM NaH<sub>2</sub>PO<sub>4</sub>; 10 mM imidazole, pH 8.0/NaOH).
Lysozyme (1 mg/mL) and protease inhibitors (P8340; Sigma) were then added. The mixture
was incubated for 30 min at 4&#x000ba;C with constant agitation. After incubation, the sample
was macerated with liquid nitrogen and centrifuged at 19,000<italic>g</italic> for 15
min at 4&#x000ba;C. The soluble protein fraction (supernatant) was collected. The obtained
soluble extracts were partially purified using nickel affinity chromatography with a
staggered elution scheme. For this scheme, a nickel resin with nitrilotriacetic acid
(Ni-NTA) was used as the stationary phase. As the mobile phase, lysis buffer (50 mM
NaH<sub>2</sub>PO<sub>4</sub>, 300 mM NaCl pH 8.0/NaOH) was used with varying
imidazole concentrations according to both the manufacturer's instructions (Qiagen) and
the purification step. The resin was equilibrated with lysis buffer with 10 mM imidazole
before the protein lysate was added and the same 10 mM imidazole concentration was used
for the washes. Finally, several consecutive elutions were performed with increasing
imidazole concentrations in lysis buffer as follows: first, three elutions with 50 mM
imidazole were performed; then, two elutions with 75 mM imidazole and, finally, four
elutions with 250 mM imidazole. The proteins that did not bind to the resin, the eluates
and the washes were analysed by SDS-PAGE and WB (<xref rid="B11" ref-type="bibr">Fra et
al. 1995</xref>, <xref rid="B26" ref-type="bibr">Ramprasad et al. 1996</xref>).</p><p>
<italic>Detection of recombinant proteins using WB</italic> - The samples were separated
by SDS-PAGE and then transferred to a polyvinylidene fluoride (Thermo-Scientific)
membrane using a 200 mA current for 2 h in transfer buffer [0.2 M glycine, 10 mM
Tris/HCl pH 8.0, 10% (v/v) methanol]. The membrane was blocked overnight with a 5% (w/v)
nonfat milk solution in tris-buffered saline with Tween 20 (TBS-T) [150 mM NaCl, 20 mM
Tris/HCl pH 7.0, 0.1% (v/v) Tween-20]. The recombinant protein was detected using the
primary antibody anti-6xHis (1:3,000), the secondary antibody biotinylated anti-mouse
IgG (1:2,000) and streptavidin-alkaline phosphatase (1:3,000) in TBS-T for the final
detection with nitro blue tetrazolium (S380C; Promega) and
5-bromo-4-chloro-3-indolyl-phosphate (S381C; Promega) substrates (<xref rid="B26" ref-type="bibr">Ramprasad et al. 1996</xref>).</p><p>
<italic>Direct enzymatic assays</italic> - The enzymatic activity of the partially
purified recombinant proteins was determined by direct enzymatic assays. The reaction
mix contained 25 mM HEPES/KOH pH 7.4, 10 mM MgCl<sub>2</sub>, 1 mM ATP (Sigma) and 1 mM
NMN (Sigma) or 1 mM NAMN (Sigma). This mix was incubated at 37&#x000ba;C for 5 min and the
enzymatic reaction was initiated by the addition of 5 &#x003bc;g of the samples: the partially
purified protein 6xHis-TcNMNAT and the recombinant form of the human isozyme
6xHis-HsNMNAT3 that was expressed from the vector pQE-30/hsnmnat3 as a positive control.
The assays were performed in 100 &#x003bc;L at 37&#x000ba;C for 30 min. To stop and neutralise the
reactions, 1.2 M HClO<sub>4</sub> and 1 M K<sub>2</sub>CO<sub>3</sub> were used,
respectively (<xref rid="B10" ref-type="bibr">Emanuelli et al. 1999</xref>). The analyte
separation (50 &#x003bc;L) was performed by reverse phase high-performance liquid
chromatographic (RP-HPLC) using a C18 column, 25 cm long x 4.6 mm internal diameter,
with a particle size of 5 &#x003bc;m (Phenomenex). An elution gradient was used with phosphate
buffer (0.1 mM potassium phosphate, pH 6.0) and methanol-phosphate buffer [0.1 mM
potassium phosphate pH 6.0 and 20% (v/v) methanol]. The separations were performed at
room temperature with a flow of 1.5 mL/min. The analyte detection was performed at 254
nm, considering the elution area under the peak and compared with the appropriate
pattern (NAD<sup>+</sup> or NAAD).</p><p>
<italic>Protein quantification</italic> - The protein concentration was determined by
densitometry analysis and/or the Bradford method using bovine serum albumin (BSA) as a
standard (Bradford 1976).</p></sec><sec sec-type="results"><title>RESULTS</title><p>
<italic>Identification of NMNAT candidate sequences in the genome of T. cruzi</italic> -
Based on a multiple sequence alignment of NMNAT isozymes (<xref rid="f01" ref-type="fig">Fig. 1</xref>), a consensus sequence of 244 residues was obtained. This sequence was
composed of residues that were highly conserved among the initial sequences. Using this
sequence, a search was performed on the genomes of four <italic>T. cruzi
</italic>strains using the BLASTP algorithm. A candidate sequence was found for each
genome, producing a total of four sequences with scores and significant p-values as
shown in <xref rid="t1" ref-type="table">Table I</xref>; each of these genes encodes a
protein of 289 aa and 32 kDa from a coding region of 870 nucleotides. For all four
genes, a biosynthetic function (predicted GO process) and a nucleotidyltransferase
activity were predicted (predicted GO function).</p><p>
<fig id="f01" orientation="portrait" position="float"><label>Fig. 1:</label><caption><title>multiple alignments of 16 nicotinamide mononucleotide adenylyltransferase
isozymes from phylogenetically divergent organisms. Sequences used were indexed
and annotated in the UniProtKB database and are shown with their corresponding
identification code and the degree of conservation of the residues along the
sequences.</title></caption><graphic xlink:href="0074-0276-mioc-110-7-0890-gf01"/></fig>
</p><p>
<table-wrap id="t1" orientation="portrait" position="float"><label>TABLE I</label><caption><title>BLASTP search results for NMNAT in genomes of <italic>Trypanosoma cruzi
</italic>strains</title></caption><table frame="hsides" rules="groups"><colgroup width="14%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" style="font-weight:normal" rowspan="1" colspan="1">Gen</th><th style="font-weight:normal" rowspan="1" colspan="1">Score</th><th style="font-weight:normal" rowspan="1" colspan="1">p (n)</th><th style="font-weight:normal" rowspan="1" colspan="1">Gene ID</th><th style="font-weight:normal" rowspan="1" colspan="1">Organism</th><th style="font-weight:normal" rowspan="1" colspan="1">Genomic location</th><th style="font-weight:normal" rowspan="1" colspan="1">Predicted gene
ontology function</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">238</td><td align="center" rowspan="1" colspan="1">5.3E-021</td><td align="center" rowspan="1" colspan="1">TcCLB.507047.170</td><td align="center" rowspan="1" colspan="1">
<italic>T. cruzi</italic> CL Brener Esmeraldo-like</td><td align="center" rowspan="1" colspan="1">TcChr17-S: 188,592-189,461
(-)</td><td align="center" rowspan="1" colspan="1">Nucleotidyltransferase
activity</td></tr><tr><td rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">237</td><td align="center" rowspan="1" colspan="1">6.8E-021</td><td align="center" rowspan="1" colspan="1">TCSYLVIO_008891</td><td align="center" rowspan="1" colspan="1">
<italic>T. cruzi</italic> Sylvio X10/1</td><td align="center" rowspan="1" colspan="1">ADWP02020923: 12,533-13,402
(-)</td><td align="center" rowspan="1" colspan="1">Nucleotidyltransferase
activity</td></tr><tr><td rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">232</td><td align="center" rowspan="1" colspan="1">2.3E-020</td><td align="center" rowspan="1" colspan="1">Tc_MARK_7577</td><td align="center" rowspan="1" colspan="1">
<italic>T. cruzi</italic> marinkellei strain B7</td><td align="center" rowspan="1" colspan="1">TcMARK_CONTIG_420: 29,693-30,562
(-)</td><td align="center" rowspan="1" colspan="1">Nucleotidyltransferase
activity</td></tr><tr><td rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">227</td><td align="center" rowspan="1" colspan="1">7.8E-020</td><td align="center" rowspan="1" colspan="1">TcCLB.509179.80</td><td align="center" rowspan="1" colspan="1">
<italic>T. cruzi</italic> CL Brener non-Esmeraldo-like</td><td align="center" rowspan="1" colspan="1">TcChr17-P: 188,641-189,510
(-)</td><td align="center" rowspan="1" colspan="1">Nucleotidyltransferase
activity</td></tr></tbody></table></table-wrap>
</p><p>
<italic>Bioinformatics analysis of the putative TcNMNAT</italic> - Using the sequence
from the genome of CL Brener Esmeraldo-like (TcCLB.507047.170), a structural analysis of
the putative TcNMNAT was performed. The primary structure showed that the putative
protein is 289 aa and has a molecular mass of 32,031.4 Da. The modelling of the
secondary structure pattern was performed using three different algorithms (<xref rid="f07" ref-type="fig">Table II</xref>). The GORIV algorithm (precision ~64%) is
based on the propensity of each aa and its neighbours to form a determined secondary
structure using a dynamic window of a determined length. The third-generation algorithm
PDH (precision &#x0003e;70%) is based on adaptive neural networks and the PREDATOR algorithm
(precision ~68-75%) is based on the recognition of aa that are potentially linked by
hydrogen bonds. All three bioinformatics methods showed similar results, with a mean of
43.90% residues located in &#x003b1;-helices, 12.57% in &#x003b2;-sheets and 44.52% in random
regions.</p><p>
<fig id="f07" orientation="portrait" position="float"><label>TABLE II</label><caption><title>Secondary structure prediction for a nicotinamide mononucleotide
adenylyltransferase of <italic>Trypanosoma cruzi</italic> candidate</title></caption><graphic xlink:href="0074-0276-mioc-110-7-0890-gt01"/></fig>
</p><p>For the modelling of the tertiary structure and the assignation of a putative function,
a tridimensional model was constructed for the sequence using the I-TASSER server. The
first of five models that were constructed by the server which had the best quality
parameters (RMSD, C-score and TM-score) is shown in <xref ref-type="fig" rid="f02">Fig.
2A</xref>. This figure shows a Rossmann fold, which is typical of proteins that bind
to nucleotides (&#x003b2;&#x003b1;&#x003b2;&#x003b1;&#x003b2; motif). The three-dimensional model confirmed the secondary
structure models that were predicted by the GORIV, PDH and PREDATOR algorithms. <xref ref-type="fig" rid="f02">Fig. 2B</xref> shows a tridimensional alignment with the
tertiary structure of the HsNMNAT (1KQO) as generated from XRD data. Clear structural
coincidences were evident in several &#x003b1;-helices and &#x003b2;-sheets of the overlapping proteins,
which had an RMSD of 0.897 &#x000c5; between 170 atom pairs.</p><p>
<fig id="f02" orientation="portrait" position="float"><label>Fig. 2A:</label><caption><title>tertiary structure model of the nicotinamide mononucleotide
adenylyltransferase of <italic>Trypanosoma cruzi</italic> (TcNMNAT)
hypothetical sequence using the I-TASSER server. &#x003b1;-helices are shown in blue
and &#x003b2;-sheets are shown in red. The N-terminal methionine and C-terminal
tyrosine residues are shown in black (C-score: -5 &#x0003c; -0.70 &#x0003c; 2, TM-score:
0.62 &#x000b1; 0.14 &#x0003e; 0.5, RMSD: 7.6 &#x000b1; 4.3 &#x000c5;); B: overlap of the TcNMNAT model with
the tertiary structure of the HsNMNAT (1KQO) protein. HsNMNAT is shown in
yellow and TcNMNAT is shown in red and blue (RMSD between 170 atom pairs: 0.897
&#x000c5;).</title></caption><graphic xlink:href="0074-0276-mioc-110-7-0890-gf02"/></fig>
</p><p>Additionally, the I-TASSER server predicted the function of the protein. The EC number,
which was predicted from comparisons with protein structures that were registered in
databases, was 2.7.7.1/18, which is consistent with an adenylyltransferase function of
the NMNAT. Likewise, the predicted GO terms for the function of the protein are
consistent with the functional characteristics that are known for NMNAT proteins:
GO:0005524, ATP binding (94% confidence), GO:0004515, nicotinate-nucleotide
adenylyltransferase activity (94% confidence) and GO:0000309, nicotinamide-nucleotide
adenylyltransferase activity (75% confidence).</p><p>
<italic>TcNMNAT cloning</italic> - Taking into account the sequence of
the<italic>TcCLB.507047.170</italic> gene from the genome of CL Brener
Esmeraldo-like, primers for the subsequent PCR amplification were designed.<italic>T.
cruzi</italic> strain CL Brener genomic DNA was used as a template. A single fragment
with an approximate size of 870 bp was amplified according to the electrophoresis
analysis (<xref rid="f03" ref-type="fig">Fig. 3</xref>). Two annealing temperatures
below the hypothetical value for the primers were used to observe which condition would
render more specific amplification. This fragment was directly ligated into the
expression vector pET100 D-TOPO, followed by transformation into the maintenance
<italic>E. coli </italic>strain TOP10.</p><p>
<fig id="f03" orientation="portrait" position="float"><label>Fig. 3:</label><caption><title>open reading frame amplification of nicotinamide mononucleotide
adenylyltransferase of <italic>Trypanosoma cruzi</italic> from genomic DNA.
Electrophoresis on a 1% agarose gel in Tris/borate/ethylenediamine tetraacetic
acid of the amplified fragment. Lanes correspond to molecular marker (100 bp
ladder), amplicons from genomic DNA using annealing temperatures of 50&#x000b0;C and
52&#x000ba;C, followed by the negative control (polymerase chain reaction with no
template). For subsequent experiments, a temperature of 50&#x000ba;C was used.</title></caption><graphic xlink:href="0074-0276-mioc-110-7-0890-gf03"/></fig>
</p><p>
<italic>Expression and purification of 6xHis-TcNMNAT</italic> - The cloned plasmids were
extracted and used to transform <italic>E. coli</italic> BL21 DE3 cells. The expression
of the recombinant protein, termed 6xHis-TcNMNAT, was induced at 37&#x000ba;C overnight with 1
mM IPTG (Fermentas). Expression was monitored using SDS-PAGE and WB against the
histidine tag that was added to the insert sequence during the cloning step in the
pET-100 D-TOPO vector (<xref rid="f04" ref-type="fig">Fig. 4</xref>). The SDS-PAGE in
<xref ref-type="fig" rid="f04">Fig. 4A</xref> shows that only one of the TcNMNAT-BL21
DE3 clones that were analysed overexpressed a 35-kDa band, which corresponded to the
expected molecular weight for the original aa sequence (32 kDa) with the histidine tag
added (3 kDa). The identity of this recombinant protein was confirmed using an
anti-histidine antibody (<xref ref-type="fig" rid="f04">Fig. 4B</xref>).</p><p>
<fig id="f04" orientation="portrait" position="float"><label>Fig. 4:</label><caption><title>induction of the 6xHis-nicotinamide mononucleotide adenylyltransferase of
<italic>Trypanosoma cruzi</italic> (TcNMNAT) in total cellular extracts from
transformed BL21 DE3 cells. A: sodium dodecyl sulfate polyacrylamide gel
electrophoresis on a 10% gel stained with Coomassie dye; B: western blot with
alkaline phosphatase. The lanes include the molecular weight marker (kDa),
induced negative control with a nontransformed strain (-) and different
inductions of transformed cells with the expression vector pET100
D-TOPO-6xHis-TcNMNAT (BL21 clones I, II, III and IV).</title></caption><graphic xlink:href="0074-0276-mioc-110-7-0890-gf04"/></fig>
</p><p>The recombinant protein was purified from the soluble fraction of the induced cells,
although the majority of the 6xHis-TcNMNAT was found in the insoluble fraction. This
process was performed by nickel affinity chromatography using Ni-NTA with a staggered
elution scheme (using imidazole), as shown in <xref rid="f05" ref-type="fig">Fig.
5</xref>. A partial purification and an enrichment of the recombinant protein were
obtained. The bands with a lower molecular weight correspond to possible degradation
products according to the recognition of the antibody.</p><p>
<fig id="f05" orientation="portrait" position="float"><label>Fig. 5:</label><caption><title>nickel affinity chromatography using Ni-NTA with staggered elutions. A:
sodium dodecyl sulfate polyacrylamide gel electrophoresis on a 12% gel stained
with Coomassie dye; B: western blot with alkaline phosphatase. The lanes
correspond to the molecular weight marker, the insoluble fraction of induced
<italic>Escherichia coli</italic> BL21 DE3 cells, the soluble fraction of
induced <italic>E. coli</italic> BL21 DE3 cells, proteins that did not bind to
the Ni-NTA resin, the first wash fraction (L1), the final wash fraction (L31),
the third elution at 50 mM imidazole and elutions using 75 mM and 250 mM
imidazole.</title></caption><graphic xlink:href="0074-0276-mioc-110-7-0890-gf05"/></fig>
</p><p>
<italic>Confirmation of the NMNAT identity using enzymatic assays</italic> - The
functional identity of the recombinant protein was verified with direct enzymatic assays
using the 250 mM imidazole elution fraction from the affinity chromatography. In these
assays, the presence of substrates and products was detected using RP-HPLC (<xref rid="f06" ref-type="fig">Fig. 6</xref>). The chromatographic profiles showed that the
hypothetical protein 6xHis-TcNMNAT is an NMNAT, which was confirmed by the presence of
the corresponding products. This enzyme showed activity for both NAMN and NMN. NAMN and
NMN are the substrates that are used by NMNAT in the presence of ATP to form
NAD<sup>+</sup> and NAAD, respectively (<xref rid="B3" ref-type="bibr">Berger et al.
2004</xref>). Therefore, this result confirms that 6xHis-TcNMNAT effectively belongs
to the NMNAT family.</p><p>
<fig id="f06" orientation="portrait" position="float"><label>Fig. 6:</label><caption><title>determination of the enzymatic activity of 6xHis-nicotinamide
mononucleotide adenylyltransferase of <italic>Trypanosoma
cruzi</italic>(TcNMNAT). A: assays performed with nicotinic acid mononucleotide
(NAMN); B: assays performed with nicotinamide mononucleotide (NMN). From the
top down, the graphs correspond to positive controls (6xHis-HsNMNAT3, the
recombinant form of the human NMNAT isozyme), assays with the 6xHis-TcNMNAT and
the negative controls (reactions with no enzyme); ATP: adenosine triphosphate;
NAD: nicotinamide adenine dinucleotide; NaMN: nicotinic acid mononucleotide;
OD: optical density.</title></caption><graphic xlink:href="0074-0276-mioc-110-7-0890-gf06"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>NAD<sup>+ </sup>synthesising routes in <italic>T. cruzi </italic>have been previously
reported, including the NMNAT gene (<xref rid="B18" ref-type="bibr">Klein et al.
2013</xref>). However, in the present study, a TcNMNAT was identified by means of
different bioinformatic and experimental strategies. This finding represents important
progress towards the understanding of the biosynthesis of pyridine nucleotides in
parasitic protozoa. In addition, this study establishes a first approach to
understanding NAD<sup>+</sup> metabolism in <italic>T. cruzi</italic> by providing
information about NAD<sup>+</sup> synthesis.</p><p>The performed sequence analysis allowed for the identification of a single gene encoding
NMNAT in the different genomes that are available for <italic>T. cruzi</italic>strains
(<xref rid="t1" ref-type="table">Table I</xref>). The structural analysis of the
putative protein, which is encoded by a gene from the strain CL Brener Esmeraldo-like,
suggests that it belongs to the NMNAT family (<xref ref-type="fig" rid="f02">Fig.
2</xref>). Based on this gene, a sequence was amplified from the genomic DNA of
<italic>T. cruzi </italic>CL Brener (<xref rid="f03" ref-type="fig">Fig. 3</xref>)
and the approximately 35 kDa recombinant protein 6xHis-TcNMNAT was successfully
expressed (<xref rid="f04" ref-type="fig">Fig. 4</xref>). In addition, partial
purification of the protein was achieved (<xref rid="f05" ref-type="fig">Fig. 5</xref>).
The purified recombinant protein was capable of synthesising NAD<sup>+</sup> and NAAD
from NAMN and NMN (<xref rid="f06" ref-type="fig">Fig. 6</xref>), respectively, which
are substrates that used by the NMNAT family of enzymes (<xref rid="B16" ref-type="bibr">Jayaram et al. 2011</xref>). These results indicate that the hypothetical sequence
analysed<italic>in silico </italic>and in vitro corresponds to that of the
TcNMNAT<italic>.</italic>
</p><p>All of the known pathways leading to the synthesis of NAD<sup>+</sup> require NMNAT.
This enzyme is of great importance for metabolism, energy supply and signal transduction
(<xref rid="B3" ref-type="bibr">Berger et al. 2004</xref>, <xref rid="B16" ref-type="bibr">Jayaram et al. 2011</xref>). This enzyme also plays an important role in
oxidative stress control and drug resistance. Therefore, the TcNMNAT represents a
potential target for the development of future drugs and other therapeutic strategies,
as has been proposed in other intracellular parasites (<xref rid="B31" ref-type="bibr">Sorci et al. 2009</xref>).</p><p>As no other NMNAT structurally related enzymes were found, it is tempting to suggest
that the NAD<sup>+</sup> levels in this organism may depend exclusively on the
expression of the NMNAT that was identified in this study. Likewise, the production of
NAD<sup>+</sup> could be explained by the use of precursors from the host. However,
the existence of additional isozymes in <italic>T. cruzi</italic> should not be
excluded. It is necessary to use other search strategies to identify new candidates that
do not meet the current prediction parameters (e.g., gene finding through hidden Markov
models).</p><p>This is the first NMNAT to be identified in the genus <italic>Trypanosoma</italic>,
which includes several pathogens that infect humans and other economically important
mammals. Thus, TcNMNAT emerges as a starting point in the understanding of the NAD<sup>+
</sup>synthetic pathway in this parasite.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p>Financial support: COLCIENCIAS, DIB-UNAL (566-2012/ 15715,19148), Venezuelan Ministry
of Higher Education, Science and Technology (IDEA Foundation, POA-2012/2013),
FONDEN-Venezuela</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aslett</surname><given-names>M</given-names></name><name><surname>Aurrecoechea</surname><given-names>C</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Brestelli</surname><given-names>J</given-names></name><name><surname>Brunk</surname><given-names>BP</given-names></name><name><surname>Carrington</surname><given-names>M</given-names></name><name><surname>Depledge</surname><given-names>DP</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Gajria</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Gardner</surname><given-names>MJ</given-names></name><name><surname>Gingle</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>G</given-names></name><name><surname>Harb</surname><given-names>OS</given-names></name><name><surname>Heiges</surname><given-names>M</given-names></name><name><surname>Hertz-Fowler</surname><given-names>C</given-names></name><name><surname>Houston</surname><given-names>R</given-names></name><name><surname>Innamorato</surname><given-names>F</given-names></name><name><surname>Iodice</surname><given-names>J</given-names></name><name><surname>Kissinger</surname><given-names>JC</given-names></name><name><surname>Kraemer</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Logan</surname><given-names>FJ</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Myler</surname><given-names>PJ</given-names></name><name><surname>Nayak</surname><given-names>V</given-names></name><name><surname>Pennington</surname><given-names>C</given-names></name><name><surname>Phan</surname><given-names>I</given-names></name><name><surname>Pinney</surname><given-names>DF</given-names></name><name><surname>Ramasamy</surname><given-names>G</given-names></name><name><surname>Rogers</surname><given-names>MB</given-names></name><name><surname>Roos</surname><given-names>DS</given-names></name><name><surname>Ross</surname><given-names>C</given-names></name><name><surname>Sivam</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>DF</given-names></name><name><surname>Srinivasamoorthy</surname><given-names>G</given-names></name><name><surname>Stoeckert</surname><given-names>CJ</given-names><suffix>Jr</suffix></name><name><surname>Subramanian</surname><given-names>S</given-names></name><name><surname>Thibodeau</surname><given-names>R</given-names></name><name><surname>Tivey</surname><given-names>A</given-names></name><name><surname>Treatman</surname><given-names>C</given-names></name><name><surname>Velarde</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><year>2010</year><article-title>TriTrypDB: a functional genomic resource for the
Trypanosomatidae</article-title><source>Nucleic Acids Res</source><volume>38</volume><fpage>D457</fpage><lpage>D462</lpage><pub-id pub-id-type="pmid">19843604</pub-id></element-citation></ref><ref id="B2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>JR</given-names></name><name><surname>Price</surname><given-names>J</given-names></name></person-group><year>1973</year><article-title>Growth in vitro of Trypanosoma cruzi as amastigotes at
temperatures below 37&#x000ba;C</article-title><source>Int J Parasitol</source><volume>3</volume><fpage>549</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">4580045</pub-id></element-citation></ref><ref id="B3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>F</given-names></name><name><surname>Ram&#x000ed;rez-Hern&#x000e1;ndez</surname><given-names>M</given-names></name><name><surname>Ziegler</surname><given-names>M</given-names></name></person-group><year>2004</year><article-title>The new life of a centenarian: signalling functions of
NAD(P)</article-title><source>Trends Biochem Sci</source><volume>29</volume><fpage>111</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">15003268</pub-id></element-citation></ref><ref id="B4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>FC</given-names></name><name><surname>Koetzle</surname><given-names>TF</given-names></name><name><surname>Williams</surname><given-names>GJB</given-names></name><name><surname>Meyer</surname><given-names>EF</given-names><suffix>Jr</suffix></name></person-group><year>1978</year><article-title>The protein data bank: a computer-based archival file
for macromolecular structures</article-title><source>Arch Biochem Biophys</source><volume>185</volume><fpage>584</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">626512</pub-id></element-citation></ref><ref id="B5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>VM</given-names></name><name><surname>Lopes</surname><given-names>UG</given-names></name><name><surname>de Souza</surname><given-names>W</given-names></name><name><surname>Vannier-Santos</surname><given-names>MA</given-names></name></person-group><year>2005</year><article-title>Cell structure and cytokinesis alterations in
multidrug-resistant Leishmania (Leishmania) amazonensis</article-title><source>Parasitol Res</source><volume>95</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15592939</pub-id></element-citation></ref><ref id="B6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group><year>1976</year><article-title>A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding</article-title><source>Anal Biochem</source><volume>72</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">942051</pub-id></element-citation></ref><ref id="B7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combet</surname><given-names>C</given-names></name><name><surname>Blanchet</surname><given-names>C</given-names></name><name><surname>Geourjon</surname><given-names>C</given-names></name><name><surname>Del&#x000e9;age</surname><given-names>G</given-names></name></person-group><year>2000</year><article-title>NPS@: Network Protein Sequence analysis</article-title><source>Trends Biochem Sci</source><volume>25</volume><fpage>147</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">10694887</pub-id></element-citation></ref><ref id="B8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieffenbach</surname><given-names>CW</given-names></name><name><surname>Lowe</surname><given-names>TM</given-names></name><name><surname>Dveksler</surname><given-names>GS</given-names></name></person-group><year>1993</year><article-title>General concepts for PCR primer design</article-title><source>PCR Methods Appl</source><volume>3</volume><fpage>S30</fpage><lpage>S37</lpage><pub-id pub-id-type="pmid">8118394</pub-id></element-citation></ref><ref id="B9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>RC</given-names></name></person-group><year>2004</year><article-title>MUSCLE: multiple sequence alignment with high accuracy
and high throughput</article-title><source>Nucleic Acids Res</source><volume>32</volume><fpage>1792</fpage><lpage>1797</lpage><pub-id pub-id-type="pmid">15034147</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emanuelli</surname><given-names>M</given-names></name><name><surname>Carnevali</surname><given-names>F</given-names></name><name><surname>Lorenzi</surname><given-names>M</given-names></name><name><surname>Raffaelli</surname><given-names>N</given-names></name><name><surname>Amici</surname><given-names>A</given-names></name><name><surname>Ruggieri</surname><given-names>S</given-names></name><name><surname>Magni</surname><given-names>G</given-names></name></person-group><year>1999</year><article-title>Identification and characterization of YLR328W, the
Saccharomyces cerevisiae structural gene encoding NMN adenylyltransferase.
Expression and characterization of the recombinant enzyme</article-title><source>FEBS Lett</source><volume>455</volume><fpage>13</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10428462</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fra</surname><given-names>AM</given-names></name><name><surname>Williamson</surname><given-names>E</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name></person-group><year>1995</year><article-title> De novo formation of caveolae in lymphocytes by
expression of VIP21-caveolin</article-title><source>Proc Natl Acad Sci USA</source><volume>92</volume><fpage>8655</fpage><lpage>8659</lpage><pub-id pub-id-type="pmid">7567992</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frishman</surname><given-names>D</given-names></name><name><surname>Argos</surname><given-names>P</given-names></name></person-group><year>1996</year><article-title>Incorporation of non-local interactions in protein
secondary structure prediction from the amino acid sequence</article-title><source>Protein Eng</source><volume>9</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">9005434</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garnier</surname><given-names>J</given-names></name><name><surname>Gibrat</surname><given-names>JF</given-names></name><name><surname>Robson</surname><given-names>B</given-names></name><name><surname>Doolittle</surname><given-names>R</given-names></name></person-group><year>1996</year><article-title>GOR secondary structure prediction method version
IV</article-title><source>Methods Enzymol</source><volume>266</volume><fpage>540</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">8743705</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasteiger</surname><given-names>E</given-names></name><name><surname>Gattiker</surname><given-names>A</given-names></name><name><surname>Hoogland</surname><given-names>C</given-names></name><name><surname>Ivanyi</surname><given-names>I</given-names></name><name><surname>Appel</surname><given-names>RD</given-names></name><name><surname>Bairoch</surname><given-names>A</given-names></name></person-group><year>2003</year><article-title>ExPASy: the proteomics server for in-depth protein
knowledge and analysis</article-title><source>Nucleic Acids Res</source><volume>31</volume><fpage>3784</fpage><lpage>3788</lpage><pub-id pub-id-type="pmid">12824418</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>U</given-names></name><name><surname>Ramachandran</surname><given-names>D</given-names></name><name><surname>Kolthur-Seetharam</surname><given-names>U</given-names></name></person-group><year>2010</year><article-title>NAD: a master regulator of transcription</article-title><source>Biochim Biophys Acta</source><volume>1799</volume><fpage>681</fpage><lpage>693</lpage><pub-id pub-id-type="pmid">20713194</pub-id></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaram</surname><given-names>HN</given-names></name><name><surname>Kusumanchi</surname><given-names>P</given-names></name><name><surname>Yalowitz</surname><given-names>JA</given-names></name></person-group><year>2011</year><article-title>NMNAT expression and its relation to NAD
metabolism</article-title><source>Curr Med Chem</source><volume>18</volume><fpage>1962</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">21517776</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirsch</surname><given-names>M</given-names></name><name><surname>Groot</surname><given-names>H</given-names></name></person-group><year>2001</year><article-title>NAD(P)H, a directly operating
antioxidant?</article-title><source>FASEB J</source><volume>15</volume><fpage>1569</fpage><lpage>1574</lpage><pub-id pub-id-type="pmid">11427489</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>CC</given-names></name><name><surname>Alves</surname><given-names>JM</given-names></name><name><surname>Serrano</surname><given-names>MG</given-names></name><name><surname>Buck</surname><given-names>GA</given-names></name><name><surname>Vasconcelos</surname><given-names>AT</given-names></name><name><surname>Sagot</surname><given-names>MF</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name><name><surname>Camargo</surname><given-names>EP</given-names></name><name><surname>Motta</surname><given-names>MC</given-names></name></person-group><year>2013</year><article-title>Biosynthesis of vitamins and cofactors in
bacterium-harbouring trypanosomatids depends on the symbiotic association as
revealed by genomic analyses</article-title><source>PLoS ONE</source><volume>8</volume><elocation-id/></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauth-Siegel</surname><given-names>RL</given-names></name><name><surname>Meiering</surname><given-names>SK</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name></person-group><year>2003</year><article-title>The parasite-specific trypanothione metabolism of
Trypanosoma and Leishmania</article-title><source>Biol Chem</source><volume>384</volume><fpage>539</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">12751784</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Niere</surname><given-names>M</given-names></name><name><surname>Ziegler</surname><given-names>M</given-names></name></person-group><year>2009</year><article-title>The NMN/NaMN adenylyltransferase (NMNAT) protein
family</article-title><source>Front Biosci</source><volume>14</volume><fpage>410</fpage><lpage>431</lpage></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magni</surname><given-names>G</given-names></name><name><surname>Di Stefano</surname><given-names>M</given-names></name><name><surname>Orsomando</surname><given-names>G</given-names></name><name><surname>Raffaelli</surname><given-names>N</given-names></name><name><surname>Ruggieri</surname><given-names>S</given-names></name></person-group><year>2009</year><article-title>NAD(P) biosynthesis enzymes as potential targets for
selective drug design</article-title><source>Curr Med Chem</source><volume>16</volume><fpage>1372</fpage><lpage>1390</lpage><pub-id pub-id-type="pmid">19355893</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miralles</surname><given-names>DM</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>C</given-names></name><name><surname>Mag&#x000e1;n</surname><given-names>R</given-names></name><name><surname>Fern&#x000e1;ndez-Ramos</surname><given-names>C</given-names></name><name><surname>Entrala</surname><given-names>E</given-names></name><name><surname>Cordova</surname><given-names>O</given-names></name><name><surname>Vargas</surname><given-names>F</given-names></name><name><surname>S&#x000e1;nchez-Moreno</surname><given-names>M</given-names></name></person-group><year>2002</year><article-title>In vitro culture and biochemical characterization of six
trypanosome isolates from Peru and Brazil</article-title><source>Exp Parasitol</source><volume>102</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">12615163</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>S</given-names></name><name><surname>Liebau</surname><given-names>E</given-names></name><name><surname>Walter</surname><given-names>RD</given-names></name><name><surname>Krauth-Siegel</surname><given-names>RL</given-names></name></person-group><year>2003</year><article-title>Thiol-based redox metabolism of protozoan
parasites</article-title><source>Trends Parasitol</source><volume>19</volume><fpage>320</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">12855383</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>CA</given-names></name><name><surname>Alonso</surname><given-names>GD</given-names></name><name><surname>Paveto</surname><given-names>MC</given-names></name><name><surname>Iribarren</surname><given-names>A</given-names></name><name><surname>Cabanas</surname><given-names>ML</given-names></name><name><surname>Torres</surname><given-names>HN</given-names></name><name><surname>Flawi&#x000e1;</surname><given-names>MM</given-names></name></person-group><year>2000</year><article-title>Trypanosoma cruzi arginine kinase characterization and
cloning. A novel energetic pathway in protozoan parasites</article-title><source>J Biol Chem</source><volume>275</volume><fpage>1495</fpage><lpage>1501</lpage><pub-id pub-id-type="pmid">10625703</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Greenblatt</surname><given-names>DM</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><year>2004</year><article-title>UCSF Chimera - a visualization system for exploratory
research and analysis</article-title><source>J Comput Chem</source><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramprasad</surname><given-names>MP</given-names></name><name><surname>Terpstra</surname><given-names>V</given-names></name><name><surname>Kondratenko</surname><given-names>N</given-names></name><name><surname>Quehenberger</surname><given-names>O</given-names></name><name><surname>Steinberg</surname><given-names>D</given-names></name></person-group><year>1996</year><article-title>Cell surface expression of mouse macrosialin and human
CD68 and their role as macrophage receptors for oxidized low density
lipoprotein</article-title><source>Proc Natl Acad Sci USA</source><volume>93</volume><fpage>14833</fpage><lpage>14838</lpage><pub-id pub-id-type="pmid">8962141</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassi</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Rassi</surname><given-names>A</given-names></name><name><surname>de Rezende</surname><given-names>JM</given-names></name></person-group><year>2012</year><article-title>American trypanosomiasis (Chagas
disease)</article-title><source>Infect Dis Clin N Am</source><volume>26</volume><fpage>275</fpage><lpage>291</lpage></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rost</surname><given-names>B</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name></person-group><year>1993</year><article-title>Prediction of protein secondary structure at better than
70% accuracy</article-title><source>J Mol Biol</source><volume>232</volume><fpage>584</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">8345525</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Kucukural</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year>2010</year><article-title>I-TASSER: a unified platform for automated protein
structure and function prediction</article-title><source>Nat Protoc</source><volume>5</volume><fpage>725</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">20360767</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year>2012</year><article-title>COFACTOR: an accurate comparative algorithm for
structure-based protein function annotation</article-title><source>Nucleic Acids Res</source><volume>40</volume><fpage>W471</fpage><lpage>W477</lpage><pub-id pub-id-type="pmid">22570420</pub-id></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorci</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Eyobo</surname><given-names>Y</given-names></name><name><surname>Rodionova</surname><given-names>I</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Kurnasov</surname><given-names>O</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names><suffix>Jr</suffix></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Osterman</surname><given-names>AL</given-names></name></person-group><year>2009</year><article-title>Targeting NAD biosynthesis in bacterial pathogens:
structure-based development of inhibitors of nicotinate mononucleotide
adenylyltransferase NadD</article-title><source>Chem Biol</source><volume>16</volume><fpage>849</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">19716475</pub-id></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrens</surname><given-names>JF</given-names></name></person-group><year>2004</year><article-title>Oxidative stress and antioxidant defenses: a target for
the treatment of diseases caused by parasitic protozoa</article-title><source>Mol Aspects Med</source><volume>25</volume><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">15051329</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>UniProt Consortium</collab></person-group><year>2014</year><article-title>Activities at the Universal Protein Resource
(UniProt)</article-title><source>Nucleic Acids Res</source><volume>42</volume><fpage>D191</fpage><lpage>D198</lpage><pub-id pub-id-type="pmid">24253303</pub-id></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year>2008</year><article-title>I-TASSER server for protein 3D structure
prediction</article-title><source>BMC Bioinformatics</source><volume>9</volume><elocation-id/></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Kurnasov</surname><given-names>O</given-names></name><name><surname>Tomchick</surname><given-names>DR</given-names></name><name><surname>Binns</surname><given-names>DD</given-names></name><name><surname>Grishin</surname><given-names>NV</given-names></name><name><surname>Marquez</surname><given-names>VE</given-names></name><name><surname>Osterman</surname><given-names>AL</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><year>2002</year><article-title>Structure of human nicotinamide/nicotinic acid
mononucleotide adenylyltransferase. Basis for the dual substrate specificity and
activation of the oncolytic agent tiazofurin</article-title><source>J Biol Chem</source><volume>277</volume><fpage>13148</fpage><lpage>13154</lpage><pub-id pub-id-type="pmid">11788603</pub-id></element-citation></ref></ref-list></back></article>